Results 231 to 240 of about 24,071 (243)

Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion

Ophthalmology, 2014
Jean-François Korobelnik, Frank G Holz, Yuichiro Ogura   +2 more
exaly  

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

Retina, 2017
Mauricio Maia
exaly  

Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization

Ophthalmology, 2015
Kyoko Ohno-Matsui, Jean-François Korobelnik, Tatsuro Ishibashi   +2 more
exaly  

Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials

Ophthalmology, 2016
Sebastian M Waldstein, Christian Simader, Giovanni Staurenghi   +2 more
exaly  

Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab

American Journal of Ophthalmology, 2013
James C Folk, H Culver Boldt, Elliott H Sohn   +2 more
exaly  

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

European Journal of Cancer, 2014
Josep Tabernero Caturla, Vladimir M Moiseyenko   +1 more
exaly  

Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2016
Hideki Koizumi, Masaaki Saito, Ichiro Maruko   +2 more
exaly  

One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy

Ophthalmology, 2015
Annabelle A Okada, Hideki Koizumi, Masaaki Saito   +2 more
exaly  

Aflibercept

Reactions Weekly, 2014
openaire   +2 more sources

Phase 1–2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer

Lancet Oncology, The, 2011
Robert L Coleman, John V Heymach, Edward F Jackson   +2 more
exaly